Physician profile
Shailendra Kumar
NPI 1376571513
$1,800.98
in general payments reported to CMS, 2019-2025
25 companies · $34.15 in 2025
The $34.15 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $119 · 2021: $501 · 2022: $768 · 2023: $71.33 · 2024: $33.10 · 2025: $34.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $254.26 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $243.02 | 2019-2022 | |
| Astellas Pharma US INC | $203.03 | 2020-2025 | Xtandi |
| Abbvie INC. | $123.08 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $102.68 | 2019-2022 | |
| Urovant Sciences INC | $88.12 | 2021-2022 | |
| Myovant Sciences INC. | $73.76 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $67.88 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $64.45 | 2021-2022 | |
| Accord Healthcare, INC. | $62.29 | 2022 | |
| Olympus America INC. | $56.28 | 2021-2023 | Itind System |
| 180 Medical, INC. | $51.23 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $46.51 | 2021-2022 | |
| Medtronic, INC. | $42.54 | 2022 | |
| Boston Scientific Corporation | $39.78 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $37.74 | 2019 | |
| Amgen INC. | $34.89 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.29 | 2022 | |
| Ferring Pharmaceuticals INC. | $34.08 | 2019 | |
| Antares Pharma, INC. | $31.48 | 2020-2021 | |
| Convatec INC. | $28.45 | 2021 | |
| Blue Earth Diagnostics | $24.73 | 2021 | |
| Clovis Oncology, INC. | $21.20 | 2020 | |
| Clarus Therapeutics INC. | $18.00 | 2021 | |
| Pfizer INC. | $17.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shailendra Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.